SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-037262
Filing Date
2021-07-20
Accepted
2021-07-20 17:04:00
Documents
14
Period of Report
2021-07-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-8k_20210719.htm   iXBRL 8-K 47041
2 EX-99.1 asmb-ex991_24.htm EX-99.1 17555
3 GRAPHIC gyqcjmenzcub000001.jpg GRAPHIC 6562
  Complete submission text file 0001564590-21-037262.txt   209903

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA asmb-20210719.xsd EX-101.SCH 5788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20210719_lab.xml EX-101.LAB 19495
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20210719_pre.xml EX-101.PRE 11641
7 EXTRACTED XBRL INSTANCE DOCUMENT asmb-8k_20210719_htm.xml XML 3568
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 211101821
SIC: 2834 Pharmaceutical Preparations